Global Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Forecast 2023-2030- Product Image

Sale

Global Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Forecast 2023-2030

Report
194 Pages
March 2024
Region: Global
360iResearch™
ID: 5206422

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Nuclear Medicine Market size was estimated at USD 4.80 billion in 2022, USD 5.14 billion in 2023, and is expected to grow at a CAGR of 7.33% to reach USD 8.45 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Nuclear Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nuclear Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Bayer AG, BJ Madan & Co., Bracco S.p.A., BWX Technologies, Inc., Cardinal Health, Inc., Curium, Eckert & Ziegler Radiopharma GmbH, Eczacibasi Monrol Nuclear Products Co., GE Healthcare, IBA Radiopharma Solutions, Institute of Isotopes Co., Ltd., Isotope Joint Stock Company, Isotopia Molecular Imaging, Jubilant DraxImage, Inc., Lantheus Holdings, Inc., Nordic Nanovector ASA, Nordion (Canada) Inc. by Sotera Health LLC, Northstar Medical Technologies LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings LLC, Radiopharm Theranostics Limited, SHINE Technologies, LLC, and Sinotau Pharmaceuticals Group.

Market Segmentation & Coverage

This research report categorizes the Nuclear Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Diagnostic Products
  - PET
    - F-18
    - SR-82/RB-82
  - SPECT
    - GA-67
    - I-123
    - TC-99m
    - TL-201
- Therapeutic Products
  - Alpha Emitters
  - Beta Emitters
    - I-131
    - Lu-117
    - Re-186
    - SM-153
    - Y-90
  - Brachytherapy
    - Cesium-131
    - Iodine-125
    - Iridium-192
    - Palladium-103
Application
- Bone Metastasis
- Cardiology
- Endocrine Tumor
- Lymphoma
- Oncology
- Thyroid
Type
- Diagnostic
  - PET Procedures
  - SPECT Procedures
- Therapeutic
  - Alpha Emitter Procedures
  - Beta Emitter Procedures
  - Brachytherapy Procedures
End-Users
- Hospitals & Diagnostic Centers
- Research institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Nuclear Medicine Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nuclear Medicine Market?
What are the technology trends and regulatory frameworks in the Nuclear Medicine Market?
What is the market share of the leading vendors in the Nuclear Medicine Market?
Which modes and strategic moves are suitable for entering the Nuclear Medicine Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Nuclear Medicine Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Incidence and Prevalence of Cancer Worldwide
5.1.1.2. Increasing Use of PET and SPECT to Diagnose Heart disease and Neurological Disorders
5.1.1.3. International Organizations’ Initiatives and Awareness Supporting Nuclear Medicine
5.1.2. Restraints
5.1.2.1. Shorter Half-Life of Nuclear Medicine
5.1.3. Opportunities
5.1.3.1. Emerging Popularity of Theranostics in Nuclear Medicine
5.1.3.2. Continuous Product Developments and Advancements in Patented Technologies
5.1.4. Challenges
5.1.4.1. Lack of Knowledge, Training, and Availability of Nuclear Medicine in Developing Countries
5.1.4.2. Limited Availability of Skilled Radiologists and Practitioners Worldwide
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Nuclear Medicine Market, by Product

6.1. Introduction
6.2. Diagnostic Products
6.3.1. PET
6.3.2.1. F-18
6.3.2.2. SR-82/RB-82
6.3.2. SPECT
6.3.3.1. GA-67
6.3.3.2. I-123
6.3.3.3. TC-99m
6.3.3.4. TL-201
6.3. Therapeutic Products
6.4.1. Alpha Emitters
6.4.2. Beta Emitters
6.4.3.1. I-131
6.4.3.2. Lu-117
6.4.3.3. Re-186
6.4.3.4. SM-153
6.4.3.5. Y-90
6.4.3. Brachytherapy
6.4.4.1. Cesium-131
6.4.4.2. Iodine-125
6.4.4.3. Iridium-192
6.4.4.4. Palladium-103

7. Nuclear Medicine Market, by Application

7.1. Introduction
7.2. Bone Metastasis
7.3. Cardiology
7.4. Endocrine Tumor
7.5. Lymphoma
7.6. Oncology
7.7. Thyroid

8. Nuclear Medicine Market, by Type

8.1. Introduction
8.2. Diagnostic
8.3.1. PET Procedures
8.3.2. SPECT Procedures
8.3. Therapeutic
8.4.1. Alpha Emitter Procedures
8.4.2. Beta Emitter Procedures
8.4.3. Brachytherapy Procedures

9. Nuclear Medicine Market, by End-Users

9.1. Introduction
9.2. Hospitals & Diagnostic Centers
9.3. Research institutes

10. Americas Nuclear Medicine Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Nuclear Medicine Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Nuclear Medicine Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Actinium Pharmaceuticals, Inc.
14.1.2. Bayer AG
14.1.3. BJ Madan & Co.
14.1.4. Bracco S.p.A.
14.1.5. BWX Technologies, Inc.
14.1.6. Cardinal Health, Inc.
14.1.7. Curium
14.1.8. Eckert & Ziegler Radiopharma GmbH
14.1.9. Eczacibasi Monrol Nuclear Products Co.
14.1.10. GE Healthcare
14.1.11. IBA Radiopharma Solutions
14.1.12. Institute of Isotopes Co., Ltd.
14.1.13. Isotope Joint Stock Company
14.1.14. Isotopia Molecular Imaging
14.1.15. Jubilant DraxImage, Inc.
14.1.16. Lantheus Holdings, Inc.
14.1.17. Nordic Nanovector ASA
14.1.18. Nordion (Canada) Inc. by Sotera Health LLC
14.1.19. Northstar Medical Technologies LLC
14.1.20. Novartis AG
14.1.21. NTP Radioisotopes SOC Ltd.
14.1.22. PharmaLogic Holdings LLC
14.1.23. Radiopharm Theranostics Limited
14.1.24. SHINE Technologies, LLC
14.1.25. Sinotau Pharmaceuticals Group
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. NUCLEAR MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. NUCLEAR MEDICINE MARKET SIZE, 2022 VS 2030
FIGURE 3. NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. NUCLEAR MEDICINE MARKET DYNAMICS
FIGURE 7. NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 12. NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
FIGURE 14. NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. NUCLEAR MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 8. NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 10. NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 14. NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 20. NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 23. NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 30. NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 44. NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 48. NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 52. NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 91. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 93. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 94. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 95. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 96. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 97. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 98. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 101. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 102. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 106. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 107. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 113. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 114. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 153. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 155. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 156. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 157. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 158. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 159. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 160. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 163. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 164. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 165. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 167. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 168. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 169. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 170. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 171. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 172. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 175. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 176. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 189. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 191. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 192. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 193. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 194. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 195. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 196. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 199. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 200. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 201. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 249. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 251. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 261. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 263. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 264. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 265. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 266. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 267. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 268. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 271. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 272. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 284. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 298. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 300. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 301. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 302. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 303. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 304. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 305. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 307. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 308. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 309. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 310. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 311. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 312. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 313. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 314. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 315. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 316. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 317. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 319. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 320. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 321. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 322. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 323. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 324. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 325. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 326. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 327. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 328. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 329. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 331. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 332. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 333. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 334. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 335. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 336. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 337. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 338. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 339. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 340. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 341. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 343. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 344. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 345. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 346. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 347. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 348. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 349. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 350. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 351. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 352. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 353. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 355. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 356. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 357. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 358. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 359. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 360. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 361. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 362. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 363. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 364. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 365. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 366. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 367. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD

Companies Mentioned

Actinium Pharmaceuticals, Inc.
Bayer AG
BJ Madan & Co.
Bracco S.p.A.
BWX Technologies, Inc.
Cardinal Health, Inc.
Curium
Eckert & Ziegler Radiopharma GmbH
Eczacibaşi Monrol Nuclear Products Co.
GE Healthcare
IBA Radiopharma Solutions
Institute of Isotopes Co., Ltd.
Isotope Joint Stock Company
Isotopia Molecular Imaging
Jubilant DraxImage, Inc.
Lantheus Holdings, Inc.
Nordic Nanovector ASA
Nordion (Canada) Inc. by Sotera Health LLC
Northstar Medical Technologies LLC
Novartis AG
NTP Radioisotopes SOC Ltd.
PharmaLogic Holdings LLC
Radiopharm Theranostics Limited
SHINE Technologies, LLC
Sinotau Pharmaceuticals Group

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	194
Published	March 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 5.14 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.45 Billion
Compound Annual Growth Rate	7.3%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Forecast 2023-2030

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Nuclear Medicine Market / Radiopharmaceuticals Market by Type (Diagnostic (SPECT-Technetium, PET-F-18), Therapeutic (Beta Emitters-Y-90, Alpha Emitters, Brachytherapy), Application (Neurology,Thyroid, Oncology), Procedures, End User - Global Forecast to 2028

Nuclear Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Product Type Coverage, Application Coverage, End User Coverage, Geographic Coverage and By Company)

Global Prostate Cancer Nuclear Medicine Diagnostics Market by Type (PET, SPECT), Product (C-11, F-18, Ga 68 PSMA) - Forecast 2024-2030

About the Nuclear Medicine Market